Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 17 Jun 2027. The National Institute on Deafness and other Communication Disorders (NIDCD) intends to re-issue a Notice of Funding Opportunity (NOFO, prior funding opportunity RFA-DC-24-008 to solicit applications for research on early-stage dissemination and implementation (D&I) in the NIDCD mission areas of hea…
Opportunity overview
- Project name
- Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?
Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 17 Jun 2027. The National Institute on Deafness and other Communication Disorders (NIDCD) intends to re-issue a Notice of Funding Opportunity (NOFO, prior funding opportunity RFA-DC-24-008 to solicit applications for research on early-stage dissemination and implementation (D&I) in the NIDCD mission areas of hea…
Who is funding Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?
Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?
The application deadline is 17 Jun 2027 00:00 (UTC).
Where will the Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.